Dimmock
Boyd K. Dimmock, Raleigh, NC US
Patent application number | Description | Published |
---|---|---|
20080239649 | Design structure for an interposer for expanded capability of a blade server chassis system - A design structure embodied in a machine readable storage medium for designing, manufacturing, and/or testing a system chassis includes multiple chassis bays configured for receiving either of a single, conventional server blade or an adapter blade is provided. The adapter blade can selectively secure a plurality of compact blades, such as a blade PC. The adapter blade includes an interposer disposed for electronically communicating each compact blade with a server interface as a separate node upon securing a compact blade within any of the adapter bays. Each compact blade may be configured as a server, a “client blade” or “blade PC”, or a companion blade providing application-specific features. Therefore, the use of an adapter blade increases the flexibility of and capability of the processor system. | 10-02-2008 |
Boyd King Dimmock, Raleigh, NC US
Patent application number | Description | Published |
---|---|---|
20080244052 | ADAPTER BLADE WITH INTERPOSER FOR EXPANDED CAPABILITY OF A BLADE SERVER CHASSIS SYSTEM - A system chassis includes multiple chassis bays configured for receiving either of a single, conventional server blade or an adapter blade. The adapter blade can selectively secure a plurality of compact blades, such as a blade PC. The adapter blade includes an interposer disposed for electronically communicating each compact blade with a server interface as a separate node upon securing a compact blade within any of the adapter bays. Each compact blade may be configured as a server, a “client blade” or “blade PC”, or a companion blade providing application-specific features. Therefore, the use of an adapter blade increases the flexibility of and capability of the processor system. | 10-02-2008 |
David Paul Dimmock, Brookfield, WI US
Patent application number | Description | Published |
---|---|---|
20130013213 | METHODS AND APPARATUS FOR IDENTIFICATION OF DISEASE ASSOCIATED MUTATIONS - In some embodiments, a non-transitory processor-readable medium includes code to cause a processor to receive a set of variants identified by a comparison of a test DNA sequence with a reference DNA sequence and associate at least one of the set of variants with at least one of a set of annotations each indicative of at least one criterion. The code includes code to cause the processor to filter, based on the set of annotations, the set of variants to identify a subset of variants from the set of variants. Each variant from the subset of variants is associated with at least one common annotation from the set of annotations. The code further includes code to cause the processor to present the subset of variants such that the subset of variants can be used to render a clinical diagnosis. | 01-10-2013 |
Gary Dimmock, Taunton GB
Patent application number | Description | Published |
---|---|---|
20130230755 | FLEXIBLE CABLE FOR LOW PROFILE ELECTRICAL DEVICE - A flexible cable with a substrate divided into at least two sections is disclosed. The first section includes a first electrically conductive track and a first attach pad, while the section includes a second and third electrically conductive tracks, as well as a second attach pad. The first section is disposed on the second section to align the attach pads and connect the first electrically conductive track to the third electrically conductive track. The resulting flexible cable can be used with a low profile electrical device. | 09-05-2013 |
James Andrew Robert Dimmock, Oxford GB
Patent application number | Description | Published |
---|---|---|
20100269895 | MULTIJUNCTION PHOTOVOLTAIC STRUCTURE WITH THREE-DIMENSIONAL SUBCELL - A multijunction photovoltaic structure includes a first subcell including a p-n or p-i-n junction with elongated structures; and a second subcell, arranged in tandem with the first subcell, and including a planar p-n or p-i-n junction. | 10-28-2010 |
20120248413 | ENERGY CONVERSION DEVICE WITH SELECTIVE CONTACTS - A resonant tunneling device includes a first semiconductor material with an energy difference between valence and conduction bands of E | 10-04-2012 |
20130220406 | VERTICAL JUNCTION SOLAR CELL STRUCTURE AND METHOD - A non-close-packed vertical junction photovoltaic device includes a substrate, a two-dimensional array of elongate nanostructures extending substantially perpendicularly from a surface of the substrate, and a thin film solar cell disposed over the nanostructures such that the thin film solar cell substantially conforms to the topography of the nanostructures. An average separation of nearest neighbor solar cell coated nanostructures is greater than zero and less than a vacuum wavelength of light corresponding to a band gap of absorption. The thin film solar cell may include an active region that conforms to the elongate nanostructures, a first electrode that conforms to a surface of the active region, and a second electrode. A separation of opposing outer surfaces of the first electrode extending along adjacent elongate nanostructures is greater than zero and less than the vacuum wavelength of the light corresponding to the band gap of the active region. | 08-29-2013 |
Jonathan R. Dimmock, Saskatoon SK
Patent application number | Description | Published |
---|---|---|
20150290183 | ANTIPARASITIC EFFECT OF BIS[3,5-BIS(BENZYLIDENE)-4-OXO-1-PIPERIDINYL]AMIDE DERIVATIVES - Embodiments are directed to compositions and methods for treating parasitic infections. Compounds have been identified from a library of anti-cancer drugs that serve as suitable agents for targeting trypanosomatids. | 10-15-2015 |
Nigel Dimmock, Leamington GB
Patent application number | Description | Published |
---|---|---|
20110243896 | ANTI-VIRAL PROTECTION WITH VIRUSES CONTAINING DEFECTIVE GENOME SEGMENTS - The invention relates to virology and the prevention and/or treatment of viral infection and disease in animals, including birds and humans. The invention relates to the field of antiviral treatments. The invention further relates to methods of stimulating innate immunity and natural interferon production in humans or animals and in component parts of humans or animals, including cells and tissues. The invention also relates to the field of defective interfering (DI) viruses, including cloned DI viruses. | 10-06-2011 |
Nigel Dimmock, Coventry GB
Patent application number | Description | Published |
---|---|---|
20090191158 | DEFECTIVE INTERFERING VIRUS - Cloned, i.e. defined, defective interfering (DI) influenza A virus is produced in embryonated hens eggs using a method which generates large quantities of DI virus material. Cloned DI virus is then used in tests on mice and ferrets given a lethal challenge of wild-type influenza A virus. When cloned DI influenza A virus is co-administered with a lethal dose of virulent influenza A virus, mice are protected compared to a control of inactivated cloned DI influenza A virus. Mice which survived the administration of cloned DI influenza A virus and infective challenge virus are three weeks later still protected against lethal challenge with infective virus. Control mice which received only cloned DI influenza A virus and no lethal challenge are not protected three weeks later on lethal challenge with infective virus. | 07-30-2009 |
20130164264 | DEFECTIVE INTERFERING VIRUS - Cloned, i.e. defined, defective interfering (DI) influenza A virus is produced in embryonated hens eggs using a method which generates large quantities of DI virus material. Co-administration of cloned DI influenza A virus with a lethal dose of virulent influenza A virus conferred protection in mice compared to a control of inactivated cloned DI influenza A virus. Control mice which received only cloned DI influenza A virus and no lethal challenge of virulent influenza A virus were not protected three weeks later on lethal challenge with infective virus. Cloned DI influenza A virus of one subtype is found to act in vivo as an effective antiviral against the same or any other sub-type of influenza A virus. The antiviral effect has been found to have both a therapeutic and a prophylactic application against influenza A infection in humans, mammals and birds. | 06-27-2013 |